ARDA study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (MMN) patients ADHERE+ data show durability of functional ...
"Multifocal Motor Neuropathy Pipeline Insight"DelveInsight's analysis reveals several companies advancing innovative therapies in the multifocal motor neuropathy clinical pipeline, with groundbreaking ...
Peripheral neuropathy symptoms often begin with pain or tingling in the hands and feet. Peripheral neuropathy is not common in children. Early diagnosis gives a better chance of reversing nerve damage ...
Prolonged, often disabling, small-fiber neuropathy in long COVID may be caused by a defective immune response, a small longitudinal study suggested. Peripheral neuropathy was identified in 59% of 17 ...
argenx Initiates Second Cohort of Phase 2 ARDA Study of Empasiprubart in Multifocal Motor Neuropathy
Amsterdam, the Netherlands—June 20, 2023—argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...
Nerve damage, also known as neuropathy, can have many causes. In some cases, neuropathy is an inherited condition. Hereditary neuropathies include a group of inherited conditions that affect the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback